Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders

This publication has 193 references indexed in Scilit:

• Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c‐Fos expression in the hypothalamus
  British Journal of Pharmacology, 2007
• Endocannabinoids block status epilepticus in cultured hippocampal neurons
  European Journal of Pharmacology, 2007
• Analgesic actions of N‐arachidonoyl‐serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors
  British Journal of Pharmacology, 2007
• Control of Spasticity in a Multiple Sclerosis Model is mediated by CB₁, not CB₂, Cannabinoid Receptors
  British Journal of Pharmacology, 2007
• Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2006
• Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain
  Pain, 2006
• AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain
  British Journal of Pharmacology, 2006
• The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus
  Neuron, 2006
• Experimental Parkinsonism Alters Anandamide Precursor Synthesis, and Functional Deficits are Improved by AM404: A Modulator of Endocannabinoid Function
  Neuropsychopharmacology, 2004
• Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia
  Neuroscience, 2004